Thursday, October 18, 2018 8:26:08 AM
Leadership there seems to have passion, but no history of execution with what will be a MISSION CRITICAL safety and efficacy trial for approval of PLX-PAD.
The 2012 debacle over the 'compassionate use' EAP, has left investors leary and short of trust for psti's leadership. Remember the company's announcement by Zami, over the seemingly 'cured' patients, who later passed away?!?!?!
https://www.benzinga.com/news/12/05/2572600/from-earlier-compassionate-use-of-pluristems-plx-cells-saves-the-life-of-a-child-
One would think we might want to select a Tried, True, Proven trial leader to conduct this CRITICAL trial. As zzaat, fda, etal. have stated, these trials are 'high risk' for psti...
IMAGINE... just imagine if 'something' goes wrong with psti being the FIRST customer... IMHO
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM